Skip to Main Content

Paper Details

The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.
Blood Adv
18
2018
AML, AML cells, CYT387, IKBKE, IKBKE/, IkB kinase, MYC, MYC gene, MYC oncoprotein, MYC promoter, Momelotinib, TANK-binding kinase 1, TBK1, YB-1, acute myeloid leukemia, murine, myeloid leukemia, myeloid leukemia cells, normal hematopoietic cells, oncogenic gene regulator, primary, primary AML cells, primary AML samples, serine, serine/threonine kinase, short hairpin RNA, threonine

Datasets

Release 1.2